Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Paul M Silva. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Paul M Silva har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NRIX / Nurix Therapeutics, Inc. | Director | 17 500 |
US:VRTX / Vertex Pharmaceuticals Incorporated | SVP & Chief Accounting Officer | 9 884 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Paul M Silva. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NRIX / Nurix Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NRIX / Nurix Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NRIX / Nurix Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Paul M Silva som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-06 |
|
4 | NRIX |
Nurix Therapeutics, Inc.
Director Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2021-10-04 |
|
4 | NRIX |
Nurix Therapeutics, Inc.
Director Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
2021-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −231 | 9 884 | −2,28 | 213,12 | −49 231 | 2 106 478 |
2021-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −915 | 10 115 | −8,30 | 212,51 | −194 447 | 2 149 539 |
2021-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −610 | 11 030 | −5,24 | 211,45 | −128 984 | 2 332 294 |
2021-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 026 | 11 640 | −8,10 | 210,13 | −215 593 | 2 445 913 |
2021-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 218 | 12 666 | −14,90 | 212,42 | −471 148 | 2 690 512 | |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −126 | 14 884 | −0,84 | 216,25 | −27 248 | 3 218 665 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −258 | 15 010 | −1,69 | 214,32 | −55 295 | 3 216 943 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −452 | 15 268 | −2,88 | 213,12 | −96 330 | 3 253 916 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −244 | 15 720 | −1,53 | 211,80 | −51 679 | 3 329 496 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −864 | 15 964 | −5,13 | 217,57 | −187 980 | 3 473 287 | |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 368 | 16 828 | −7,52 | 212,62 | −290 864 | 3 577 969 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 343 | 18 196 | −11,41 | 211,82 | −496 294 | 3 854 277 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −584 | 20 539 | −2,76 | 210,05 | −122 669 | 4 314 217 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 740 | 21 123 | −11,48 | 211,75 | −580 195 | 4 472 795 | |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 23 863 | −0,87 | 211,32 | −44 377 | 5 042 729 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 288 | 24 073 | −5,08 | 210,45 | −271 060 | 5 066 163 |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −651 | 25 361 | −2,50 | 214,16 | −139 418 | 5 431 312 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 3 634 | 26 012 | 16,24 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 3 226 | 22 378 | 16,84 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 4 220 | 19 152 | 28,26 | ||||
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −612 | 3 669 | −14,30 | ||||
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −466 | 4 656 | −9,10 | ||||
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −74 | 14 932 | −0,49 | 272,87 | −20 192 | 4 074 495 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −373 | 15 006 | −2,43 | 272,15 | −101 512 | 4 083 883 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −211 | 15 379 | −1,35 | 270,92 | −57 164 | 4 166 479 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −420 | 15 590 | −2,62 | 270,12 | −113 450 | 4 211 171 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 612 | 16 010 | 3,97 | 155,57 | 95 209 | 2 490 676 | |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 466 | 15 398 | 3,12 | 187,53 | 87 389 | 2 887 587 | |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 1 618 | −33,33 | ||||
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −19 | 14 932 | −0,13 | 279,61 | −5 313 | 4 175 137 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −429 | 14 951 | −2,79 | 278,92 | −119 657 | 4 170 133 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −310 | 15 380 | −1,98 | 277,73 | −86 096 | 4 271 487 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −51 | 15 690 | −0,32 | 276,00 | −14 076 | 4 330 440 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 15 741 | 5,42 | 86,52 | 69 995 | 1 361 911 | |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Options (Right to Buy) |
M - Exercise | −860 | 0 | −100,00 | ||||
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 14 932 | −0,67 | 295,78 | −29 578 | 4 416 587 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −250 | 15 032 | −1,64 | 294,99 | −73 748 | 4 434 290 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 15 282 | −1,29 | 294,18 | −58 836 | 4 495 659 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −50 | 15 482 | −0,32 | 291,97 | −14 598 | 4 520 280 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 15 532 | −0,64 | 287,86 | −28 786 | 4 471 042 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −60 | 15 632 | −0,38 | 285,71 | −17 143 | 4 466 219 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 15 692 | −0,63 | 284,56 | −28 456 | 4 465 316 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 15 792 | 5,76 | 90,29 | 77 649 | 1 425 860 | |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −47 | 14 932 | −0,31 | 288,04 | −13 538 | 4 301 013 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 | 14 979 | −0,09 | 287,00 | −4 018 | 4 298 973 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 | 14 993 | −0,13 | 285,51 | −5 710 | 4 280 651 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 15 013 | −0,07 | 282,85 | −2 828 | 4 246 427 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 | 15 023 | −0,13 | 281,81 | −5 636 | 4 233 632 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −30 | 15 043 | −0,20 | 279,89 | −8 397 | 4 210 385 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 15 073 | −0,07 | 275,71 | −2 757 | 4 155 777 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −611 | 4 281 | −12,49 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −465 | 5 122 | −8,32 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −70 | 14 932 | −0,47 | 275,17 | −19 262 | 4 108 838 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 15 002 | −1,38 | 274,41 | −57 626 | 4 116 699 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −240 | 15 212 | −1,55 | 273,53 | −65 647 | 4 160 938 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −328 | 15 452 | −2,08 | 272,40 | −89 347 | 4 209 125 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −149 | 15 780 | −0,94 | 270,51 | −40 306 | 4 268 648 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −79 | 15 929 | −0,49 | 269,41 | −21 283 | 4 291 432 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 611 | 16 008 | 3,97 | 155,57 | 95 053 | 2 490 365 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 465 | 15 397 | 3,11 | 187,53 | 87 201 | 2 887 399 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 2 427 | −25,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −59 | 14 932 | −0,39 | 264,75 | −15 620 | 3 953 247 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 14 991 | −0,66 | 262,83 | −26 283 | 3 940 085 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 15 091 | −1,31 | 261,55 | −52 310 | 3 947 051 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −250 | 15 291 | −1,61 | 259,97 | −64 992 | 3 975 201 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 15 541 | −1,27 | 259,21 | −51 842 | 4 028 383 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 15 741 | 5,42 | 86,52 | 69 995 | 1 361 911 | |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −859 | 860 | −49,97 | ||||
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −166 | 14 932 | −1,10 | 252,26 | −41 875 | 3 766 746 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −193 | 15 098 | −1,26 | 250,29 | −48 306 | 3 778 878 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 15 291 | −0,97 | 248,96 | −37 344 | 3 806 847 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 15 441 | −0,96 | 247,18 | −37 077 | 3 816 706 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 15 591 | −0,95 | 245,62 | −36 843 | 3 829 461 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −50 | 15 741 | −0,32 | 244,09 | −12 204 | 3 842 221 |
2020-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 15 791 | 5,75 | 90,29 | 77 559 | 1 425 769 | |
2020-04-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 891 | 4 892 | −49,99 | ||||
2020-04-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 891 | 14 932 | −24,67 | 255,57 | −1 249 993 | 3 816 171 |
2020-04-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 891 | 19 823 | 32,76 | 155,57 | 760 893 | 3 083 864 | |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 14 932 | −0,99 | 238,40 | −35 760 | 3 559 789 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −90 | 15 082 | −0,59 | 236,85 | −21 316 | 3 572 172 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 15 172 | −0,98 | 235,49 | −35 324 | 3 572 854 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 15 322 | −0,97 | 234,50 | −35 175 | 3 593 009 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −120 | 15 472 | −0,77 | 232,40 | −27 888 | 3 595 693 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −137 | 15 592 | −0,87 | 231,17 | −31 670 | 3 604 403 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −283 | 15 729 | −1,77 | 229,66 | −64 994 | 3 612 322 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −864 | 16 012 | −5,12 | 239,23 | −206 695 | 3 830 551 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −202 | 16 876 | −1,18 | 245,74 | −49 639 | 4 147 108 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 17 078 | −1,61 | 245,00 | −68 600 | 4 184 110 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −202 | 17 358 | −1,15 | 243,85 | −49 258 | 4 232 748 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −640 | 17 560 | −3,52 | 242,80 | −155 392 | 4 263 568 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −240 | 18 200 | −1,30 | 241,95 | −58 068 | 4 403 490 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −1 248 | 18 440 | −6,34 | 241,50 | −301 392 | 4 453 260 | |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 102 | 19 688 | −5,30 | 247,93 | −273 219 | 4 881 246 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 120 | 20 790 | −5,11 | 246,84 | −276 461 | 5 131 804 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 700 | 21 910 | −7,20 | 245,89 | −418 013 | 5 387 450 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 560 | 23 610 | −6,20 | 244,90 | −382 044 | 5 782 089 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −380 | 25 170 | −1,49 | 243,59 | −92 564 | 6 131 160 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 673 | 25 550 | −15,46 | 240,95 | −1 125 959 | 6 156 272 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −466 | 5 587 | −7,70 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −31 | 30 223 | −0,10 | 242,47 | −7 517 | 7 328 171 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −92 | 30 254 | −0,30 | 240,46 | −22 122 | 7 274 877 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −343 | 30 346 | −1,12 | 238,73 | −81 884 | 7 244 501 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 466 | 30 689 | 1,54 | 187,53 | 87 389 | 5 755 108 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 3 226 | 30 223 | 11,95 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 2 918 | 26 997 | 12,12 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 320 | 24 079 | 35,59 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 3 236 | −20,00 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 290 | 0 | −100,00 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 17 759 | −1,17 | 232,75 | −48 878 | 4 133 407 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −630 | 17 969 | −3,39 | 231,46 | −145 820 | 4 159 105 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −809 | 18 599 | −4,17 | 231,03 | −186 903 | 4 296 927 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −240 | 19 408 | −1,22 | 230,28 | −55 267 | 4 469 274 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 19 648 | −1,06 | 228,91 | −48 071 | 4 497 624 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 19 858 | 4,25 | 86,52 | 69 995 | 1 718 114 | |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 290 | 19 049 | 7,26 | 91,05 | 117 454 | 1 734 411 | |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 396 | 6 053 | −18,74 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 396 | 17 759 | −7,29 | 238,65 | −333 155 | 4 238 185 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 396 | 19 155 | 7,86 | 187,53 | 261 792 | 3 592 137 | |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −860 | 1 719 | −33,35 | ||||
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −860 | 17 759 | −4,62 | 229,38 | −197 267 | 4 073 559 |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 18 619 | 4,84 | 90,29 | 77 649 | 1 681 110 | |
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −13 750 | 0 | −100,00 | ||||
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 750 | 17 759 | −43,64 | 231,89 | −3 188 488 | 4 118 135 |
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 750 | 31 509 | 77,43 | 131,89 | 1 813 488 | 4 155 722 | |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −2 427 | 4 045 | −37,50 | ||||
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −2 578 | 2 579 | −49,99 | ||||
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −3 867 | 1 290 | −74,99 | ||||
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −16 758 | 0 | −100,00 | ||||
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 17 759 | −0,56 | 220,07 | −22 007 | 3 908 223 |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 648 | 17 859 | −41,46 | 219,37 | −2 774 592 | 3 917 729 |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 040 | 30 507 | −24,76 | 218,70 | −2 195 748 | 6 671 881 |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 842 | 40 547 | −6,55 | 217,68 | −618 647 | 8 826 271 |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 427 | 43 389 | 5,93 | 86,52 | 209 984 | 3 754 016 | |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 578 | 40 962 | 6,72 | 90,29 | 232 768 | 3 698 459 | |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 867 | 38 384 | 11,20 | 91,05 | 352 090 | 3 494 863 | |
2020-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 16 758 | 34 517 | 94,36 | 109,14 | 1 828 968 | 3 767 185 | |
2019-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −161 | 17 759 | −0,90 | 165,41 | −26 631 | 2 937 516 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −160 | 17 759 | −0,89 | 188,70 | −30 192 | 3 351 123 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −984 | 17 919 | −5,21 | 187,10 | −184 106 | 3 352 645 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 668 | 18 903 | −8,11 | 186,72 | −311 449 | 3 529 568 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −715 | 20 571 | −3,36 | 181,09 | −129 479 | 3 725 202 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 100 | 21 286 | −8,98 | 180,38 | −378 798 | 3 839 569 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 400 | 23 386 | −5,65 | 179,35 | −251 090 | 4 194 279 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 7 449 | 7 449 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 000 | 24 786 | 25,27 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 2 917 | 19 786 | 17,29 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 4 220 | 16 869 | 33,36 | ||||
2019-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 5 157 | −20,00 | ||||
2019-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 12 649 | −9,25 | 193,00 | −248 777 | 2 441 257 |
2019-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 13 938 | 10,19 | 91,05 | 117 363 | 1 269 055 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 6 472 | −11,11 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −120 | 12 649 | −0,94 | 188,33 | −22 600 | 2 382 186 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 268 | 12 769 | −15,08 | 186,85 | −423 776 | 2 385 888 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −450 | 15 037 | −2,91 | 186,17 | −83 776 | 2 799 438 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 15 487 | −3,73 | 185,11 | −111 066 | 2 866 799 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −809 | 16 087 | −4,79 | 189,19 | −153 055 | 3 043 500 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 16 896 | 5,03 | 86,52 | 69 995 | 1 461 842 | |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −859 | 5 157 | −14,28 | ||||
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −859 | 5 157 | −14,28 | ||||
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 6 446 | −16,66 | ||||
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −859 | 16 087 | −5,07 | 190,29 | −163 459 | 3 061 195 |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −859 | 16 087 | −5,07 | 190,29 | −163 459 | 3 061 195 |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 16 946 | 5,34 | 90,29 | 77 559 | 1 530 054 | |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 16 946 | 5,34 | 90,29 | 77 559 | 1 530 054 | |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 087 | −7,42 | 191,05 | −246 263 | 3 073 421 |
2019-01-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 376 | 8,01 | 91,05 | 117 363 | 1 582 085 | |
2018-12-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 809 | 7 281 | 12,50 | ||||
2018-12-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −809 | 16 087 | −4,79 | 186,52 | −150 895 | 3 000 547 |
2018-12-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 16 896 | 5,03 | 86,52 | 69 995 | 1 461 842 | |
2018-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 | 16 087 | −0,07 | 163,75 | −1 965 | 2 634 246 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 8 090 | −9,09 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −809 | 16 087 | −4,79 | 174,20 | −140 928 | 2 802 355 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 16 896 | 5,03 | 86,52 | 69 995 | 1 461 842 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 7 735 | −14,28 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 087 | −7,42 | 174,59 | −225 047 | 2 808 629 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 376 | 8,01 | 91,05 | 117 363 | 1 582 085 | |
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −860 | 0 | −100,00 | ||||
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −860 | 16 087 | −5,07 | 179,85 | −154 671 | 2 893 247 |
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 16 947 | 5,35 | 96,87 | 83 308 | 1 641 656 | |
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −860 | 6 875 | −11,12 | ||||
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −860 | 16 087 | −5,07 | 175,02 | −150 517 | 2 815 547 |
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 16 947 | 5,35 | 90,29 | 77 649 | 1 530 145 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 8 899 | −8,33 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 9 024 | −12,50 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −859 | 860 | −49,97 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −809 | 16 087 | −4,79 | 161,57 | −130 710 | 2 599 177 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 16 896 | 5,03 | 86,52 | 69 995 | 1 461 842 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 087 | −7,42 | 166,05 | −214 038 | 2 671 246 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 376 | 8,01 | 91,05 | 117 363 | 1 582 085 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −859 | 16 087 | −5,07 | 171,87 | −147 636 | 2 764 873 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 16 946 | 5,34 | 96,87 | 83 211 | 1 641 559 | |
2018-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −201 | 16 087 | −1,23 | 155,78 | −31 312 | 2 506 033 |
2018-04-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −859 | 7 735 | −10,00 | ||||
2018-04-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −859 | 16 087 | −5,07 | 166,05 | −142 637 | 2 671 246 |
2018-04-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 16 946 | 5,34 | 90,29 | 77 559 | 1 530 054 | |
2018-04-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −138 | 16 087 | −0,85 | 161,99 | −22 355 | 2 605 933 |
2018-04-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 300 | 16 225 | −16,90 | 161,18 | −531 894 | 2 615 146 |
2018-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 437 | 19 525 | −14,97 | 158,49 | −544 730 | 3 094 517 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 213 | 22 962 | −15,50 | 153,41 | −646 316 | 3 522 600 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 9 783 | 9 783 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 4 219 | 27 175 | 18,38 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 322 | 22 956 | 38,01 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −809 | 9 708 | −7,69 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 0 | −100,00 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 098 | 16 634 | −11,20 | 163,08 | −342 142 | 2 712 673 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 809 | 18 732 | 4,51 | 86,52 | 69 995 | 1 620 693 | |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 77,31 | 99 653 | 1 385 627 | |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 10 313 | −11,11 | ||||
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 634 | −7,19 | 169,42 | −218 382 | 2 818 132 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 91,05 | 117 363 | 1 631 889 | |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −8 594 | 1 719 | −83,33 | ||||
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 594 | 16 634 | −34,07 | 174,11 | −1 496 301 | 2 896 146 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 594 | 25 228 | 51,67 | 96,87 | 832 501 | 2 443 836 | |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 719 | 8 594 | −16,67 | ||||
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 11 602 | −10,00 | ||||
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 008 | 16 634 | −15,31 | 166,05 | −499 478 | 2 762 076 |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 719 | 19 642 | 9,59 | 90,29 | 155 209 | 1 773 476 | |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 91,05 | 117 363 | 1 631 889 | |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 427 | 10 517 | −18,75 | ||||
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 427 | 16 634 | −12,73 | 161,52 | −392 009 | 2 686 724 |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 427 | 19 061 | 14,59 | 86,52 | 209 984 | 1 649 158 | |
2017-12-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 1 289 | −50,00 | ||||
2017-12-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 634 | −7,19 | 152,31 | −196 328 | 2 533 525 |
2017-12-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 77,31 | 99 653 | 1 385 627 | |
2017-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −23 | 16 634 | −0,14 | 147,29 | −3 388 | 2 450 022 |
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 2 578 | −33,33 | ||||
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 634 | −7,19 | 152,88 | −197 062 | 2 543 006 |
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 77,31 | 99 653 | 1 385 627 | |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 289 | 12 891 | −9,09 | ||||
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 289 | 16 634 | −7,19 | 151,80 | −195 670 | 2 525 041 |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 17 923 | 7,75 | 91,05 | 117 363 | 1 631 889 | |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −860 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −860 | 16 634 | −4,92 | 152,99 | −131 571 | 2 544 836 |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 17 494 | 5,17 | 83,36 | 71 690 | 1 458 300 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 16 634 | −2,92 | 161,92 | −80 960 | 2 693 377 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 937 | 17 134 | −14,63 | 161,91 | −475 530 | 2 774 166 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 437 | 10 313 | −25,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 437 | 10 313 | −25,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −6 445 | 14 180 | −31,25 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −6 445 | 14 180 | −31,25 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 867 | 16 758 | −18,75 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 437 | 10 313 | −25,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −8 438 | 0 | −100,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 500 | 0 | −100,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −40 006 | 20 071 | −66,59 | 161,00 | −6 440 966 | 3 231 431 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 437 | 60 077 | 6,07 | 90,29 | 310 327 | 5 424 352 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 6 445 | 56 640 | 12,84 | 91,05 | 586 817 | 5 157 072 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 867 | 50 195 | 8,35 | 109,14 | 422 044 | 5 478 282 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 437 | 46 328 | 8,01 | 96,87 | 332 942 | 4 487 793 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 437 | 42 891 | 8,71 | 83,36 | 286 508 | 3 575 394 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 438 | 39 454 | 27,21 | 45,11 | 380 638 | 1 779 770 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 500 | 31 016 | 16,97 | 48,74 | 219 330 | 1 511 720 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 6 445 | 26 516 | 32,11 | 77,31 | 498 263 | 2 049 952 | |
2017-06-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 577 | 4 297 | −37,49 | ||||
2017-06-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 577 | 20 071 | −11,38 | 133,36 | −343 669 | 2 676 669 |
2017-06-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 577 | 22 648 | 12,84 | 83,36 | 214 819 | 1 887 937 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 867 | 10 312 | −27,27 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 867 | 20 071 | −16,15 | 127,31 | −492 308 | 2 555 239 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 867 | 23 938 | 19,27 | 77,31 | 298 958 | 1 850 647 | |
2017-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −271 | 20 071 | −1,33 | 114,64 | −31 067 | 2 300 939 |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 688 | 8 438 | −16,67 | ||||
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 688 | 20 071 | −7,76 | 106,30 | −179 434 | 2 133 547 |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 688 | 21 759 | 8,41 | 45,11 | 76 146 | 981 548 | |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 12 944 | 12 944 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 321 | 20 071 | 45,97 | ||||
2016-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 | 13 750 | −0,01 | 94,14 | −94 | 1 294 425 |
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 687 | 10 126 | −14,28 | ||||
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 687 | 13 750 | −10,93 | 95,11 | −160 451 | 1 307 762 |
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 687 | 18 812 | 9,85 | 45,11 | 76 101 | 848 609 | |
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 375 | 0 | −100,00 | ||||
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 375 | 15 437 | −17,94 | 88,92 | −300 105 | 1 372 658 |
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 17 125 | 24,55 | 37,86 | 127 778 | 648 352 | |
2016-07-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 13 750 | 13 750 | |||||
2016-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −202 | 13 750 | −1,45 | 82,06 | −16 576 | 1 128 325 |
2016-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 13 750 | −7,41 | 88,44 | −97 284 | 1 216 050 |
2016-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 14 850 | −6,90 | 87,49 | −96 239 | 1 299 226 |
2016-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 15 950 | −4,78 | 86,69 | −69 352 | 1 382 706 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 16 750 | −1,18 | 93,06 | −18 612 | 1 558 755 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −662 | 16 950 | −3,76 | 92,43 | −61 189 | 1 566 688 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 900 | 17 612 | −9,74 | 91,07 | −173 033 | 1 603 925 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 300 | 19 512 | −10,54 | 89,96 | −206 908 | 1 755 300 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 20 625 | 20 625 | |||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 875 | 21 812 | 46,03 | 0,01 | 69 | 218 | |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 | 14 937 | −0,01 | 123,00 | −123 | 1 837 251 |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −127 | 14 938 | −0,84 | 122,31 | −15 533 | 1 827 067 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 14 937 | −3,24 | 126,64 | −63 320 | 1 891 622 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 638 | 15 437 | −9,59 | 126,04 | −206 454 | 1 945 679 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 17 075 | −5,01 | 124,98 | −112 482 | 2 134 034 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 17 975 | −2,18 | 123,37 | −49 348 | 2 217 576 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −860 | 6 874 | −11,12 | ||||
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 375 | −0,54 | 132,97 | −13 297 | 2 443 324 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −160 | 18 475 | −0,86 | 132,63 | −21 221 | 2 450 339 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 635 | −0,53 | 131,26 | −13 126 | 2 446 030 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 18 735 | −1,58 | 127,98 | −38 394 | 2 397 705 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 19 035 | −0,52 | 125,54 | −12 554 | 2 389 654 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 19 135 | −0,52 | 123,17 | −12 317 | 2 356 858 |
2015-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 19 235 | 4,68 | 83,36 | 71 690 | 1 603 430 | |
2015-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 4 500 | −20,00 | ||||
2015-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −125 | 18 375 | −0,68 | 124,80 | −15 600 | 2 293 200 |
2015-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 18 500 | −2,12 | 123,67 | −49 468 | 2 287 895 |
2015-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 18 900 | −3,08 | 122,71 | −73 626 | 2 319 219 |
2015-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 500 | 6,12 | 48,74 | 54 832 | 950 430 | |
2015-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 13 750 | 13 750 | |||||
2015-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 0 | −100,00 | ||||
2015-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 375 | −0,54 | 124,48 | −12 448 | 2 287 320 |
2015-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 025 | 18 475 | −5,26 | 123,72 | −126 813 | 2 285 727 |
2015-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 500 | 6,12 | 51,75 | 58 219 | 1 009 125 | |
2015-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −135 | 18 375 | −0,73 | 123,85 | −16 720 | 2 275 744 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 289 | 14 179 | −8,33 | ||||
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 687 | 11 813 | −12,50 | ||||
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 375 | −0,54 | 125,20 | −12 520 | 2 300 550 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 18 475 | −1,07 | 123,85 | −24 770 | 2 288 129 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 000 | 18 675 | −5,08 | 122,90 | −122 900 | 2 295 158 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 676 | 19 675 | −7,85 | 121,92 | −204 338 | 2 398 776 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 289 | 21 351 | 6,43 | 77,31 | 99 653 | 1 650 646 | |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 687 | 20 062 | 9,18 | 45,11 | 76 101 | 904 997 | |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 3 375 | −25,00 | ||||
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −216 | 18 375 | −1,16 | 128,22 | −27 696 | 2 356 042 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −332 | 18 591 | −1,75 | 127,09 | −42 194 | 2 362 730 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −577 | 18 923 | −2,96 | 126,15 | −72 789 | 2 387 136 |
2015-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 500 | 6,12 | 37,86 | 42 592 | 738 270 | |
2015-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −859 | 7 734 | −10,00 | ||||
2015-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 18 375 | −1,08 | 125,71 | −25 142 | 2 309 921 |
2015-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 18 575 | −2,62 | 123,85 | −61 925 | 2 300 514 |
2015-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −159 | 19 075 | −0,83 | 122,41 | −19 463 | 2 334 971 |
2015-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 859 | 19 234 | 4,67 | 83,36 | 71 606 | 1 603 346 | |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 5 625 | −16,67 | ||||
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 375 | −0,54 | 134,09 | −13 409 | 2 463 904 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 475 | −0,54 | 133,06 | −13 306 | 2 458 284 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 18 575 | −0,54 | 131,60 | −13 160 | 2 444 470 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 18 675 | −1,06 | 130,57 | −26 114 | 2 438 395 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −625 | 18 875 | −3,21 | 127,95 | −79 969 | 2 415 056 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 500 | 6,12 | 48,74 | 54 832 | 950 430 | |
2015-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 1 125 | −50,00 | ||||
2015-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 125 | 18 375 | −5,77 | 128,60 | −144 675 | 2 363 025 |
2015-04-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 500 | 6,12 | 51,75 | 58 219 | 1 009 125 | |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 18 375 | −1,61 | 127,45 | −38 235 | 2 341 894 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 18 675 | −5,56 | 125,90 | −138 490 | 2 351 182 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −750 | 19 775 | −3,65 | 125,05 | −93 788 | 2 472 864 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 20 525 | −0,48 | 122,10 | −12 210 | 2 506 102 |
2015-02-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 290 | 15 468 | −7,70 | ||||
2015-02-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −860 | 8 593 | −9,10 | ||||
2015-02-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 150 | 20 625 | −9,44 | 119,85 | −257 678 | 2 471 906 |
2015-02-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 290 | 22 775 | 6,00 | 77,31 | 99 730 | 1 760 735 | |
2015-02-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 860 | 21 485 | 4,17 | 83,36 | 71 690 | 1 790 990 | |
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 449 | 20 625 | −6,56 | 113,16 | −163 969 | 2 333 925 |
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 988 | 22 074 | −8,26 | 112,71 | −224 067 | 2 487 961 |
2015-02-13 |
|
5 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 3 000 | 17 187 | 21,15 | 0,01 | 30 | 172 | |
2015-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 688 | 13 500 | −11,11 | ||||
2015-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −388 | 24 062 | −1,59 | 110,76 | −42 975 | 2 665 107 |
2015-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 24 450 | −3,55 | 109,74 | −98 766 | 2 683 143 |
2015-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 25 350 | −1,55 | 108,81 | −43 524 | 2 758 334 |
2015-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 688 | 25 750 | 7,02 | 45,11 | 76 146 | 1 161 582 | |
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
A - Award | 20 625 | 20 625 | |||||
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 875 | 24 062 | 40,00 | 0,01 | 69 | 241 | |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −938 | 0 | −100,00 | ||||
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 17 187 | −0,58 | 111,32 | −11 132 | 1 913 257 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 17 287 | −0,58 | 109,50 | −10 950 | 1 892 926 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 17 387 | −1,70 | 108,16 | −32 448 | 1 880 578 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −438 | 17 687 | −2,42 | 107,04 | −46 884 | 1 893 216 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 938 | 18 125 | 5,46 | 38,80 | 36 394 | 703 250 | |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 4 500 | −20,00 | ||||
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −157 | 17 187 | −0,91 | 110,76 | −17 389 | 1 903 632 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −668 | 17 344 | −3,71 | 109,89 | −73 407 | 1 905 932 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 18 012 | −1,64 | 108,11 | −32 433 | 1 947 277 |
2015-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 18 312 | 6,55 | 37,86 | 42 592 | 693 292 | |
2015-01-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 6 750 | −14,29 | ||||
2015-01-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 17 187 | −2,27 | 126,27 | −50 508 | 2 170 202 |
2015-01-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −725 | 17 587 | −3,96 | 125,26 | −90 814 | 2 202 948 |
2015-01-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 18 312 | 6,55 | 48,74 | 54 832 | 892 527 | |
2015-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 2 250 | −33,33 | ||||
2015-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 14 187 | −2,74 | 123,05 | −49 220 | 1 745 710 |
2015-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 14 587 | −2,02 | 122,28 | −36 684 | 1 783 698 |
2015-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −425 | 14 887 | −2,78 | 120,61 | −51 259 | 1 795 521 |
2015-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 15 312 | 7,93 | 51,75 | 58 219 | 792 396 | |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 14 187 | −7,20 | 120,48 | −132 528 | 1 709 250 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 713 | 15 287 | −10,08 | 119,82 | −205 252 | 1 831 688 |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −3 867 | 16 758 | −18,75 | ||||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −4 297 | 9 453 | −31,25 | ||||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 164 | 17 000 | −32,44 | 119,85 | −978 455 | 2 037 450 |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 867 | 25 164 | 18,16 | 77,31 | 298 958 | 1 945 429 | |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 297 | 21 297 | 25,28 | 83,36 | 358 198 | 1 775 318 | |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 687 | 15 188 | −10,00 | ||||
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 17 000 | −0,58 | 114,29 | −11 429 | 1 942 930 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 17 100 | −3,93 | 112,93 | −79 051 | 1 931 103 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −887 | 17 800 | −4,75 | 112,07 | −99 406 | 1 994 846 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 687 | 18 687 | 9,92 | 45,11 | 76 101 | 842 971 | |
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 5 625 | −16,67 | ||||
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −937 | 938 | −49,97 | ||||
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 17 000 | −0,58 | 113,09 | −11 309 | 1 922 530 |
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 962 | 17 100 | −10,29 | 111,97 | −219 685 | 1 914 687 |
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 19 062 | 6,27 | 37,86 | 42 592 | 721 687 | |
2014-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 937 | 17 937 | 5,51 | 38,80 | 36 356 | 695 956 | |
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 7 875 | −12,50 | ||||
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −287 | 17 000 | −1,66 | 111,21 | −31 917 | 1 890 570 |
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −229 | 17 287 | −1,31 | 110,60 | −25 327 | 1 911 942 |
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −490 | 17 516 | −2,72 | 109,43 | −53 621 | 1 916 776 |
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −119 | 18 006 | −0,66 | 108,54 | −12 916 | 1 954 371 |
2014-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 18 125 | 6,62 | 48,74 | 54 832 | 883 412 | |
2014-10-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 3 375 | −25,00 | ||||
2014-10-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −173 | 17 000 | −1,01 | 108,67 | −18 800 | 1 847 390 |
2014-10-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −770 | 17 173 | −4,29 | 107,97 | −83 137 | 1 854 169 |
2014-10-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −182 | 17 943 | −1,00 | 106,80 | −19 438 | 1 916 312 |
2014-10-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 18 125 | 6,62 | 51,75 | 58 219 | 937 969 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −10 125 | 16 875 | −37,50 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −3 375 | 9 000 | −27,27 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −3 375 | 9 000 | −27,27 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −3 375 | 6 750 | −33,33 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 813 | 1 875 | −60,00 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 407 | 0 | −100,00 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −938 | 0 | −100,00 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −25 408 | 17 000 | −59,91 | 99,85 | −2 536 989 | 1 697 450 |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 125 | 42 408 | 31,36 | 45,11 | 456 739 | 1 913 025 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 32 283 | 11,67 | 48,74 | 164 498 | 1 573 473 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 28 908 | 13,22 | 37,86 | 127 778 | 1 094 457 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 25 533 | 15,23 | 51,75 | 174 656 | 1 321 333 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 813 | 22 158 | 14,54 | 38,80 | 109 144 | 859 730 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 407 | 19 345 | 7,84 | 33,82 | 47 585 | 654 248 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 938 | 17 938 | 5,52 | 39,05 | 36 629 | 700 479 | |
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −577 | 17 000 | −3,28 | 89,51 | −51 647 | 1 521 670 |
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 450 | 17 577 | −7,62 | 88,76 | −128 702 | 1 560 135 |
2014-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 13 750 | 13 750 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 20 625 | 20 625 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 875 | 18 625 | 58,51 | 0,01 | 69 | 186 | |
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 10 125 | −10,00 | ||||
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −937 | 4 688 | −16,66 | ||||
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −937 | 4 688 | −16,66 | ||||
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 141 | 11 750 | −8,85 | 67,22 | −76 698 | 789 835 |
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 858 | 12 891 | −12,60 | 66,64 | −123 817 | 859 056 |
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 14 749 | 8,26 | 37,86 | 42 592 | 558 397 | |
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 937 | 13 624 | 7,39 | 38,80 | 36 356 | 528 611 | |
2013-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 937 | 12 687 | 7,97 | 39,05 | 36 590 | 495 427 | |
2013-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 12 375 | −8,33 | ||||
2013-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 11 750 | −0,84 | 78,29 | −7 829 | 919 908 |
2013-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 025 | 11 850 | −7,96 | 76,56 | −78 474 | 907 236 |
2013-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 12 875 | 9,57 | 48,74 | 54 832 | 627 528 | |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 7 875 | −12,50 | ||||
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −468 | 1 407 | −24,96 | ||||
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −125 | 11 750 | −1,05 | 73,22 | −9 152 | 860 335 |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −754 | 11 875 | −5,97 | 72,26 | −54 484 | 858 088 |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 12 629 | −3,81 | 71,57 | −35 785 | 903 858 |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −214 | 13 129 | −1,60 | 70,41 | −15 068 | 924 413 |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 13 343 | 9,21 | 51,75 | 58 219 | 690 500 | |
2013-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 468 | 12 218 | 3,98 | 33,82 | 15 828 | 413 213 | |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −938 | 5 625 | −14,29 | ||||
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −938 | 5 625 | −14,29 | ||||
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 11 750 | −0,84 | 79,56 | −7 956 | 934 830 |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 776 | 11 850 | −13,03 | 78,59 | −139 576 | 931 292 |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 938 | 13 626 | 7,39 | 38,80 | 36 394 | 528 689 | |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 938 | 12 688 | 7,98 | 39,05 | 36 629 | 495 466 | |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −1 125 | 11 250 | −9,09 | ||||
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 11 750 | −1,67 | 80,33 | −16 066 | 943 878 |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −925 | 11 950 | −7,18 | 79,13 | −73 195 | 945 604 |
2013-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 12 875 | 9,57 | 37,86 | 42 592 | 487 448 | |
2013-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 13 750 | 13 750 | |||||
2013-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −1 125 | 13 500 | −7,69 | ||||
2013-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −483 | 11 750 | −3,95 | 87,29 | −42 161 | 1 025 658 |
2013-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −542 | 12 233 | −4,24 | 86,17 | −46 704 | 1 054 118 |
2013-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 12 775 | −0,78 | 84,38 | −8 438 | 1 077 954 |
2013-07-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 12 875 | 9,57 | 48,74 | 54 832 | 627 528 | |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −469 | 0 | −100,00 | ||||
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −469 | 11 750 | −3,84 | 85,75 | −40 217 | 1 007 562 |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 469 | 12 219 | 3,99 | 33,28 | 15 608 | 406 648 | |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −1 125 | 9 000 | −11,11 | ||||
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −469 | 1 875 | −20,01 | ||||
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 11 750 | −0,84 | 87,33 | −8 733 | 1 026 128 |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 494 | 11 850 | −11,20 | 86,34 | −128 992 | 1 023 129 |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 13 344 | 9,21 | 51,75 | 58 219 | 690 552 | |
2013-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 469 | 12 219 | 3,99 | 33,82 | 15 862 | 413 247 | |
2013-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 11 750 | −0,84 | 80,50 | −8 050 | 945 875 |
2013-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −509 | 11 850 | −4,12 | 79,49 | −40 460 | 941 956 |
2013-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −937 | 2 813 | −24,99 | ||||
2013-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Commom Stock |
S - Sale | X | −707 | 11 750 | −5,68 | 77,56 | −54 835 | 911 330 |
2013-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −230 | 12 457 | −1,81 | 76,12 | −17 508 | 948 227 |
2013-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 937 | 12 687 | 7,97 | 39,05 | 36 590 | 495 427 | |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −937 | 6 563 | −12,49 | ||||
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 11 750 | −0,84 | 78,12 | −7 812 | 917 910 |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 11 850 | −1,66 | 76,66 | −15 332 | 908 421 |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −637 | 12 050 | −5,02 | 75,76 | −48 259 | 912 908 |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 937 | 12 687 | 7,97 | 38,80 | 36 356 | 492 256 | |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 12 375 | −8,33 | ||||
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −425 | 11 750 | −3,49 | 77,59 | −32 976 | 911 682 |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 12 175 | −5,44 | 77,17 | −54 019 | 939 545 |
2013-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 12 875 | 9,57 | 37,86 | 42 592 | 487 448 | |
2013-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 125 | 14 625 | −7,14 | ||||
2013-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −725 | 11 750 | −5,81 | 80,79 | −58 573 | 949 282 |
2013-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 12 475 | −3,11 | 80,24 | −32 096 | 1 000 994 |
2013-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 12 875 | 9,57 | 48,74 | 54 832 | 627 528 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −2 250 | 15 750 | −12,50 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −3 375 | 13 500 | −20,00 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −4 500 | 10 125 | −30,77 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −2 813 | 7 500 | −27,28 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −2 813 | 7 500 | −27,28 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −1 875 | 2 344 | −44,44 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −1 875 | 2 344 | −44,44 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −2 813 | 3 750 | −42,86 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | −235 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −22 549 | 11 750 | −65,74 | 81,50 | −1 837 744 | 957 625 |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 250 | 34 299 | 7,02 | 48,74 | 109 665 | 1 671 733 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 32 049 | 11,77 | 37,86 | 127 778 | 1 213 375 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 500 | 28 674 | 18,62 | 51,75 | 232 875 | 1 483 880 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 813 | 24 174 | 13,17 | 38,80 | 109 144 | 937 951 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 875 | 21 361 | 9,62 | 33,82 | 63 412 | 722 429 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 813 | 19 486 | 16,87 | 39,05 | 109 848 | 760 928 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 875 | 16 673 | 12,67 | 33,28 | 62 400 | 554 877 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 813 | 14 798 | 23,47 | 33,55 | 94 376 | 496 473 | |
2013-04-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 235 | 11 985 | 2,00 | 32,16 | 7 558 | 385 438 | |
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 27 000 | 27 000 | |||||
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 625 | 11 750 | 91,84 | 0,01 | 56 | 118 | |
2012-07-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 18 000 | 18 000 | |||||
2012-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −839 | 6 125 | −12,05 | 61,15 | −51 305 | 374 544 | |
2012-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
I - Other | −1 483 | 0 | −100,00 | 60,35 | −89 499 | ||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −3 375 | 14 625 | −18,75 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −12 187 | 2 813 | −81,25 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −3 281 | 4 219 | −43,75 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −4 687 | 10 313 | −31,25 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −8 437 | 6 563 | −56,25 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −1 125 | 16 875 | −6,25 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −3 515 | 235 | −93,73 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −5 156 | 2 344 | −68,75 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −7 032 | 0 | −100,00 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −1 000 | 6 125 | −14,04 | 61,08 | −61 080 | 374 115 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −55 295 | 7 125 | −88,59 | 60,85 | −3 364 701 | 433 556 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 375 | 62 420 | 5,72 | 51,75 | 174 656 | 3 230 235 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 12 187 | 59 045 | 26,01 | 33,55 | 408 874 | 1 980 960 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 281 | 46 858 | 7,53 | 33,82 | 110 963 | 1 584 738 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 687 | 43 577 | 12,05 | 38,80 | 181 856 | 1 690 788 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 437 | 38 890 | 27,70 | 39,05 | 329 465 | 1 518 654 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 125 | 30 453 | 3,84 | 37,86 | 42 592 | 1 152 951 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 515 | 29 328 | 13,62 | 32,16 | 113 042 | 943 188 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 156 | 25 813 | 24,96 | 33,28 | 171 592 | 859 057 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 032 | 20 657 | 51,61 | 18,93 | 133 116 | 391 037 | |
2012-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 500 | 13 625 | 122,45 | 36,27 | 272 025 | 494 179 | |
2012-03-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −6 875 | 6 125 | −52,88 | 39,36 | −270 600 | 241 080 | |
2012-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 18 000 | 18 000 | |||||
2012-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 4 500 | 13 000 | 52,94 | 0,01 | 45 | 130 | |
2011-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −27 | 8 500 | −0,32 | 29,74 | −803 | 252 790 |